Journal of Cardiovascular Translational Research最新文献

筛选
英文 中文
Collagen Prolyl 4-Hydroxylase: An Emerging Key Player in Cardiac Fibrosis. 胶原脯氨酸- 4-羟化酶:在心脏纤维化中的关键作用。
IF 2.6 3区 医学
Journal of Cardiovascular Translational Research Pub Date : 2026-09-08 DOI: 10.1007/s12265-026-10843-y
Wei Hua, Zai-Xin Yu, Li-Huang Zha
{"title":"Collagen Prolyl 4-Hydroxylase: An Emerging Key Player in Cardiac Fibrosis.","authors":"Wei Hua, Zai-Xin Yu, Li-Huang Zha","doi":"10.1007/s12265-026-10843-y","DOIUrl":"10.1007/s12265-026-10843-y","url":null,"abstract":"<p><p>Collagen prolyl 4-hydroxylase (C-P4H) is a key enzyme that controls collagen maturation and fibrotic matrix buildup. Cardiac fibrosis is a major pathological basis of many cardiovascular diseases. It is marked by excess collagen deposition and extracellular matrix stiffening, which lead to myocardial stiffness and progression to heart failure. Growing evidence shows that C-P4H and its related subunits are abnormally expressed in several cardiac diseases linked to fibrosis and are closely associated with disease development. C-P4H regulates intracellular procollagen maturation and secretion and thereby indirectly influences extracellular matrix remodeling. Targeting C-P4H has also shown antifibrotic effects in several fibrosis models, which suggests that this enzyme may serve as a potential therapeutic target in cardiac fibrosis. In this review, we briefly summarize the structure and function of C-P4H, discuss its regulatory roles in the development of cardiac fibrosis, and outline the therapeutic prospects of targeting C-P4H.</p>","PeriodicalId":15224,"journal":{"name":"Journal of Cardiovascular Translational Research","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148912124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alamandine Attenuates Hypoxia-Induced Atrial Fibrillation in Rats: Involvement of Endoplasmic Reticulum Stress and Pyroptosis Pathways. almanmanine减轻大鼠缺氧引起的心房颤动:内质网应激和焦亡通路的参与。
IF 2.6 3区 医学
Journal of Cardiovascular Translational Research Pub Date : 2026-09-05 DOI: 10.1007/s12265-026-10837-w
Lijia Yang, Wenwen Yang, Mengzhu Zhou, Kangyin Chen, Tong Liu, Xuewen Wang, Changle Liu
{"title":"Alamandine Attenuates Hypoxia-Induced Atrial Fibrillation in Rats: Involvement of Endoplasmic Reticulum Stress and Pyroptosis Pathways.","authors":"Lijia Yang, Wenwen Yang, Mengzhu Zhou, Kangyin Chen, Tong Liu, Xuewen Wang, Changle Liu","doi":"10.1007/s12265-026-10837-w","DOIUrl":"10.1007/s12265-026-10837-w","url":null,"abstract":"<p><p>Chronic intermittent hypoxia (CIH) constitutes the primary pathophysiological disturbance in obstructive sleep apnoea (OSA), recognised as an independent risk factor for cardiovascular disease. The protective peptide alamandine (ALA), emerging as a novel component of the renin-angiotensin system, holds potential for elucidating molecular mechanisms underlying OSA-associated atrial fibrillation (AF). This study demonstrates that ALA treatment downregulates the expression of molecules associated with the GRP78/ATF6/CHOP pathway and pyroptosis-related proteins, while simultaneously mitigating atrial electrophysiological and structural remodelling and reducing susceptibility to AF. These findings suggest that the cardioprotective effects of ALA may be mediated through regulation of ERS and pyroptosis-related pathways, providing preliminary experimental evidence for its potential application in AF therapy. However, the precise molecular mechanisms require further functional validation.</p>","PeriodicalId":15224,"journal":{"name":"Journal of Cardiovascular Translational Research","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148897433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Innovation and Challenges in Materials for Transcatheter Aortic Valves. 经导管主动脉瓣材料的创新与挑战。
IF 2.6 3区 医学
Journal of Cardiovascular Translational Research Pub Date : 2026-09-05 DOI: 10.1007/s12265-026-10840-1
Pramod Dorishetty, Aden Carlton, Leon Neethling, Filippo Valente
{"title":"Innovation and Challenges in Materials for Transcatheter Aortic Valves.","authors":"Pramod Dorishetty, Aden Carlton, Leon Neethling, Filippo Valente","doi":"10.1007/s12265-026-10840-1","DOIUrl":"10.1007/s12265-026-10840-1","url":null,"abstract":"<p><p>Transcatheter Aortic valve implantation (TAVI) procedure has been revolutionizing the Aortic Stenosis (AS) treatment over the last 20 years, because of its minimally invasive approach and fast postoperative recovery. However, innovation in valve material compatible with TAVI procedure present significant challenges, as they must endure the demanding conditions of catheter-based delivery. This review outlines the fundamental material requirements and challenges in the design and manufacturing of TAVI valves. It compares the existing TAVI devices made from animal tissues and polymers, and identifies the key factors that are limiting their adoption for widespread clinical use. While biological valves remain the predominant choice in current clinical TAVI practice, major future innovation is likely to arise from advances in polymer science aimed at overcoming the key limitations like calcification and limited durability. Fully polymeric valve systems are still at an early stage of development, but they hold considerable long-term potential due to their tunable mechanical properties, resistance to calcification, and potential for scalable manufacturing, that could revolutionize the field.</p>","PeriodicalId":15224,"journal":{"name":"Journal of Cardiovascular Translational Research","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13550074/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148906000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Trajectory of Epigenetic Chromatin Remodeling in Cardiometabolic Disease and its Therapeutic Implications. 表观遗传染色质重塑在心脏代谢疾病中的轨迹及其治疗意义。
IF 2.6 3区 医学
Journal of Cardiovascular Translational Research Pub Date : 2026-08-28 DOI: 10.1007/s12265-026-10820-5
Mirjana Macvanin, Aleksandra Klisic
{"title":"The Trajectory of Epigenetic Chromatin Remodeling in Cardiometabolic Disease and its Therapeutic Implications.","authors":"Mirjana Macvanin, Aleksandra Klisic","doi":"10.1007/s12265-026-10820-5","DOIUrl":"10.1007/s12265-026-10820-5","url":null,"abstract":"<p><p>The pathogenesis and progression of cardiometabolic diseases (CMD) are intricately linked to epigenetic regulation mediated by chromatin remodeling. Modifications to histones, such as post-translational acetylation and methylation, along with DNA methylation, alter chromatin structure and accessibility, resulting in transient or irreversible alterations in gene expression without accompanying changes in the DNA sequence. Herein, we outline the trajectory of epigenetic chromatin remodeling across various tissues, focusing on the liver-heart axis and the crosstalk between various epigenetic mechanisms in CMD pathogenesis and progression. We provide a list of drugs that target crucial epigenetic enzymes for CMD treatment. Furthermore, we propose possible future directions for the development of effective therapies targeting the crosstalk interaction points of epigenetic mechanisms involved in CMD.</p>","PeriodicalId":15224,"journal":{"name":"Journal of Cardiovascular Translational Research","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148850804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AMPKγ2-Myosin Interaction: A Glycogen-Independent Trigger for PRKAG2 Cardiomyopathy. ampkγ - 2-肌球蛋白相互作用:PRKAG2心肌病的糖原独立触发。
IF 2.6 3区 医学
Journal of Cardiovascular Translational Research Pub Date : 2026-08-28 DOI: 10.1007/s12265-026-10835-y
Jiaxin Song, Yujiao Zhu, Yanjuan Lin, Yihua Bei
{"title":"AMPKγ2-Myosin Interaction: A Glycogen-Independent Trigger for PRKAG2 Cardiomyopathy.","authors":"Jiaxin Song, Yujiao Zhu, Yanjuan Lin, Yihua Bei","doi":"10.1007/s12265-026-10835-y","DOIUrl":"10.1007/s12265-026-10835-y","url":null,"abstract":"","PeriodicalId":15224,"journal":{"name":"Journal of Cardiovascular Translational Research","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148850809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emerging Myostatin and Metabolic Hormone Pathway Modulators in Cardiometabolic Disease: Mechanisms, Evidence, and Therapeutic Potential. 心脏代谢疾病中新出现的肌生长抑制素和代谢激素通路调节剂:机制、证据和治疗潜力。
IF 2.6 3区 医学
Journal of Cardiovascular Translational Research Pub Date : 2026-08-27 DOI: 10.1007/s12265-026-10839-8
Abiya Ahad, Darshan Hullon, Mandana Akhavan, Zahra Oskouyan
{"title":"Emerging Myostatin and Metabolic Hormone Pathway Modulators in Cardiometabolic Disease: Mechanisms, Evidence, and Therapeutic Potential.","authors":"Abiya Ahad, Darshan Hullon, Mandana Akhavan, Zahra Oskouyan","doi":"10.1007/s12265-026-10839-8","DOIUrl":"10.1007/s12265-026-10839-8","url":null,"abstract":"<p><p>Cardiometabolic disease comprises obesity, type 2 diabetes, heart failure, and sarcopenic obesity, which share interconnected mechanisms including muscle wasting, metabolic dysfunction, fibrosis, mitochondrial impairment, and chronic inflammation. Current therapies primarily target individual risk factors rather than these shared pathways. This review summarizes mechanistic and translational evidence on three emerging pathway modulators-myostatin (MSTN), fibroblast growth factor 21 (FGF21), and growth differentiation factor 15 (GDF15)-and their integration with incretin biology, AMPK/mTOR signaling, fibrosis, and metabolic regulation. Myostatin inhibition increases lean body mass but has shown inconsistent functional benefits. FGF21 analogs improve insulin sensitivity, lipid metabolism, hepatic steatosis, and cardiac energetics. GDF15 functions as both a biomarker and therapeutic target for metabolic stress and cachexia, while GLP-1/GIP therapies favorably influence inflammation, fibrosis, and substrate utilization. Coordinated modulation of these pathways, supported by precision phenotyping and biomarker-guided monitoring, offers a promising strategy for comprehensive cardiometabolic remodeling.</p>","PeriodicalId":15224,"journal":{"name":"Journal of Cardiovascular Translational Research","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148840206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metabolic Signatures of Atrial Functional Impairment in Paroxysmal Atrial Fibrillation Patients: A CMR Strain-metabolomics Study. 阵发性心房颤动患者心房功能损害的代谢特征:CMR菌株代谢组学研究
IF 2.6 3区 医学
Journal of Cardiovascular Translational Research Pub Date : 2026-08-24 DOI: 10.1007/s12265-026-10833-0
Tianyi Shi, Bin Liu, Xiaoyu Lian, Chao Peng, Yanjing Wang, Wendi Shi, Heyuan Chen, Sihui He, Huan Sun
{"title":"Metabolic Signatures of Atrial Functional Impairment in Paroxysmal Atrial Fibrillation Patients: A CMR Strain-metabolomics Study.","authors":"Tianyi Shi, Bin Liu, Xiaoyu Lian, Chao Peng, Yanjing Wang, Wendi Shi, Heyuan Chen, Sihui He, Huan Sun","doi":"10.1007/s12265-026-10833-0","DOIUrl":"10.1007/s12265-026-10833-0","url":null,"abstract":"<p><p>Atrial fibrillation (AF) is the most common clinical arrhythmia. Patients with paroxysmal atrial fibrillation (PAF) may exhibit reversible changes in atrial function at an early stage. Identifying biomarkers for this stage is crucial for delaying disease progression. This study integrated cardiac magnetic resonance (CMR) atrial strain analysis with untargeted metabolomics. Despite similar left atrial sizes, significant differences in atrial strain were observed among PAF patients. Seven differential metabolites-phosphatidylcholine, inosine, bilirubin, biliverdin, 3-methylhistidine, L-tryptophan, and pantothenic acid-were identified as potential biomarkers associated with declining atrial function. These findings suggest that peripheral blood metabolites are associated with atrial functional impairment in PAF patients. However, these exploratory findings warrant further investigation in larger prospective cohorts.</p>","PeriodicalId":15224,"journal":{"name":"Journal of Cardiovascular Translational Research","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148813006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Right Heart Remodeling and Autonomic Function After Atrial Septal Defect Closure in Children: Surgical Versus Transcatheter Approaches. 儿童房间隔缺损关闭后右心重塑和自主神经功能:手术与经导管入路。
IF 2.6 3区 医学
Journal of Cardiovascular Translational Research Pub Date : 2026-08-13 DOI: 10.1007/s12265-026-10831-2
Nida Gülderen Kalay Şentürk, Ali Karakaş, Samed Cihad Çelik, Hazal Cansu Çulpan, İlker Kemal Yücel, Reyhan Dedeoğlu
{"title":"Right Heart Remodeling and Autonomic Function After Atrial Septal Defect Closure in Children: Surgical Versus Transcatheter Approaches.","authors":"Nida Gülderen Kalay Şentürk, Ali Karakaş, Samed Cihad Çelik, Hazal Cansu Çulpan, İlker Kemal Yücel, Reyhan Dedeoğlu","doi":"10.1007/s12265-026-10831-2","DOIUrl":"10.1007/s12265-026-10831-2","url":null,"abstract":"<p><p>Atrial septal defect (ASD) closure relieves chronic right ventricular (RV) volume overload; however, the extent to which RV mechanics and autonomic regulation normalize in the mid-term remains uncertain. Patients with isolated secundum ASD who had undergone surgical or transcatheter closure were compared with healthy controls of similar age, sex, and body surface area. Despite successful closure, ASD patients demonstrated subclinical impairment in RV systolic function and persistent enlargement of parasternal RV end-diastolic diameter (p < 0.001). Autonomic assessment revealed a higher LF/HF ratio despite preserved parasympathetic indices, indicating subtle sympathovagal imbalance. Right atrial size correlated positively with parasympathetic markers (RMSSD, pNN50) and inversely with LF/HF. Surgically treated patients exhibited lower TAPSE values and a higher prevalence of abnormal RV S' compared with transcatheter closure. These findings suggest that ASD closure does not uniformly restore RV mechanics or autonomic balance. Larger prospective studies are needed to clarify the clinical significance of these observations.</p>","PeriodicalId":15224,"journal":{"name":"Journal of Cardiovascular Translational Research","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148724912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association Between Gut Microbiota Dysbiosis and Bilirubin Metabolism Dysregulation in Children with Heart Failure. 心衰患儿肠道菌群失调与胆红素代谢失调的关系
IF 2.6 3区 医学
Journal of Cardiovascular Translational Research Pub Date : 2026-08-13 DOI: 10.1007/s12265-026-10834-z
Wei Wei, Lisi Zhou, Yuan Huang, Zhongyuan Lu, Rongyuan Zhang, Ming Zeng, Xu Wang
{"title":"Association Between Gut Microbiota Dysbiosis and Bilirubin Metabolism Dysregulation in Children with Heart Failure.","authors":"Wei Wei, Lisi Zhou, Yuan Huang, Zhongyuan Lu, Rongyuan Zhang, Ming Zeng, Xu Wang","doi":"10.1007/s12265-026-10834-z","DOIUrl":"10.1007/s12265-026-10834-z","url":null,"abstract":"<p><p>Patients with heart failure (HF) demonstrate dysregulation in bilirubin metabolism. The specific characteristics of intestinal bilirubin metabolism in HF remain unclear. This study involved metagenomic sequencing and metabolomic profiling of fecal samples from 45 children with HF and 32 healthy children. Serum total bilirubin levels were 11.3umol/L, 19.4umol/L and 5.0umol/L in HF New York Heart Association (NYHA) I-II, NYHA III-IV and control group (p < 0.001 ), and the median gut microbiome health index (GMHI) were - 0.78, -1.53 and 0.09 in each (p < 0.001). The abundance of 2 bacteria species containing bilirubin reductase, Ruminococcus gnavus (p = 0.028) and Clostridium sp.M62/1 (p = 0.002) significantly decreased in NYHA III-IV group. The gut downstream bilirubin products, urobilinogen and stercobilin were decreased in the HF group; while the upstream bilirubin products, unconjugated and conjugated bilirubin increased. Dysbiosis of the gut microbiome and the decrease of bilirubin reductase containing bacteria in pediatric HF patients related to a reduction in gut bilirubin metabolism.</p>","PeriodicalId":15224,"journal":{"name":"Journal of Cardiovascular Translational Research","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148760323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dynamic Evaluation of Vascular Remodeling and Aneurysm Progression Using Blood-Pool Contrast-Enhanced In Vivo Micro-CT in a Rodent Model. 在啮齿类动物模型中使用血池增强显微ct动态评估血管重构和动脉瘤进展。
IF 2.6 3区 医学
Journal of Cardiovascular Translational Research Pub Date : 2026-08-13 DOI: 10.1007/s12265-026-10825-0
Amber Hendrickx, Margaux Schols, Geert Maleux, Kasia Błażejczyk, Bart Meuris, Nele Famaey, Filip Rega, Greetje Vande Velde
{"title":"Dynamic Evaluation of Vascular Remodeling and Aneurysm Progression Using Blood-Pool Contrast-Enhanced In Vivo Micro-CT in a Rodent Model.","authors":"Amber Hendrickx, Margaux Schols, Geert Maleux, Kasia Błażejczyk, Bart Meuris, Nele Famaey, Filip Rega, Greetje Vande Velde","doi":"10.1007/s12265-026-10825-0","DOIUrl":"10.1007/s12265-026-10825-0","url":null,"abstract":"<p><p>Vascular graft remodeling and aneurysm progression are commonly studied in small animal models, but non-terminal methods for their assessment remain limited. This study evaluated contrast-enhanced micro-CT as a tool for longitudinal, in vivo monitoring of vascular grafts in rodents. Using a transplant model in which a pulmonary artery segment was implanted into the recipient's abdominal aorta, creating a pulmonary vascular graft, we compared a molecular iodinated contrast agent with a nanoparticle-based agent. The molecular agent was rapidly cleared, resulting in insufficient vascular opacification for graft visualization or quantification. In contrast, the nanoparticle agent provided prolonged vascular enhancement, enabling high-resolution imaging and quantitative assessment of graft morphology and aneurysm development over time. These findings demonstrate that contrast-enhanced micro-CT, particularly using nanoparticulate blood-pool contrast agents, enables a longitudinal, non-terminal evaluation of vascular grafts in rodents, enabling quantitative monitoring of graft remodeling, overcoming the limitations of traditional post-mortem, single timepoint analyses.</p>","PeriodicalId":15224,"journal":{"name":"Journal of Cardiovascular Translational Research","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148761362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书